Skip to main content
. Author manuscript; available in PMC: 2014 Jun 2.
Published in final edited form as: Ann Surg Oncol. 2013 Sep 18;21(3):862–867. doi: 10.1245/s10434-013-3266-1

TABLE 2.

Clinical outcomes according to treatment received

Variable mOS (m) 95 % CI p value
Any adjuvant therapy 16.4 14–21 0.0007
No adjuvant therapy 6.3 1.5–10.1
Type of adjuvant therapy
 CT 21.5 13.4–24.6 0.76
 CRT 16.8 13.9–23.1
Lymph node statusa
 Negative 24 19.8–34.2 0.0003
 Positive 13.8 10.9–15.2
Resection margin status
 Negative (R0) 16.6 13.4–20.1 0.36
 Positive (R1)ab 16.4 13.8–23.6
Tumor size (cm)
 <3 16.4 12.1–21 0.0924
 ≥3 16.8 13.7–24
Tumor differentiation
 Well-moderate 15.2 8.7–25.6 0.54
 Poor 16.4 13.9–23
Sex
 Male 17.1 13.9–24.3 0.55
 Female 16.4 12.2–23.1
Age (years)
 <70 20.4 13.7–29.9 0.0514
 ≥70 15.2 13.6–18.3

Bold values are statistically significant

a

In patients receiving adjuvant therapy

b

Microscopically positive